Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Researchers first took an interest in 1,3-Butanediol early in the twentieth century, drawn by its role as an intermediate in both industrial chemistry and biology labs. Initially produced in small quantities for laboratory investigations, commercial production only ramped up as the pharmaceutical and polymer industries recognized its versatility. The introduction of regulatory standards like the BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia) marked a shift. Industry processes turned more controlled, regulated, and safe—not for mere consistency, but because downstream users needed assurance over both purity and performance. The push to meet strict pharmacopoeial monographs has since made 1,3-Butanediol a staple raw material, with applications far removed from its modest experimental origins.
1,3-Butanediol comes to market as a colorless, viscous liquid prized for both its purity and stability. Manufacturers sell it in a range of grades, but the BP, EP, and USP pharma grades guarantee a high standard for pharmaceutical, food, and cosmetic industries—an assurance established through defined limits on impurities and robust batch-testing data. In practice, this means medical formulators and research chemists buy a product that consistently delivers on specification, especially when used as a solvent, humidifier, or polymer building block. For a material that appears so routine, its presence underpins a broad swath of consumer and specialty products.
1,3-Butanediol holds the molecular formula C4H10O2, giving it a molecular weight around 90.12 g/mol. It appears as a transparent and mildly sweet-smelling liquid, with a boiling point near 207°C, melting at approximately -50°C, and a density close to 1.005 g/cm³ at room temperature. Its two hydroxyl groups contribute to high solubility in water, a quality that enables widespread use in pharmaceuticals as well as in cosmetic and food preparations. Chemical stability remains high under ambient conditions, but as with any diol, reactive partners—especially oxidizers or acid chlorides—transform it rapidly.
A bottle labeled 1,3-Butanediol BP EP USP will arrive with specifications that spell out purity typically above 99.5%, residual solvent analysis, water content (often under 0.2%), and tight controls on related organic impurities. Every lot comes with a certificate of analysis detailing these values along with batch and expiration information, which not only maintains traceability, but fulfills compliance requirements. Handlers will notice hazard and precautionary statements on the packaging, following GHS (Globally Harmonized System) guidelines—details that matter for safety audits and laboratory management. With its pharma grade, users count on stability data, recommended storage conditions, and validated test methods included in regulatory submissions.
Large-scale producers favor catalytic hydrogenation of 3-hydroxybutanal or aldol condensation of formaldehyde and acetaldehyde, resulting in high-yield methods with less environmental burden than legacy chemical reductions. The hydrogenation process uses a metal catalyst, frequently Raney nickel or noble metals, under moderate temperature and pressure to steer the conversion efficiently. Some biotechnology companies have shifted toward fermentation-based production, using genetically modified strains to turn sugars and renewable feedstocks into 1,3-Butanediol, a greener approach that reduces reliance on petroleum sources. These methods have not only driven more sustainable supply chains, they have also brought down costs and led to consistent materials that pass the demanding tests outlined in global pharmacopoeias.
Chemists working with 1,3-Butanediol find it a useful synthon, meaning it’s a reliable building block for synthesizing other molecules. The two primary alcohol groups react with acids to form esters—a common strategy for adding controlled-release properties to drugs or tweaking the solubility in cosmeceutical blends. Oxidation yields 3-hydroxybutanal or even butyric acid, while ring-closure reactions with certain diacids produce polyesters. Working with protective groups allows selective elaboration of one site without altering the other, expanding utility for specialty materials development or active pharmaceutical ingredients. Its reactivity profiles guide process safety, and experienced chemists use these behaviors to reduce risk and avoid byproduct formation.
In the marketplace and scientific literature, 1,3-Butanediol pops up under a menu of synonyms: 1,3-Butylene glycol, 1,3-Butylene alcohol, and Butane-1,3-diol all refer to the same structural compound. Commercial product names might differ by manufacturer, reflecting branding or regulatory jurisdiction, but trained professionals recognize the importance of double-checking chemical abstracts numbers (CAS 107-88-0) to confirm the product’s identity across suppliers and global regions. This helps prevent mix-ups in plant operations and ensures safe, legal compliance in pharmaceutical manufacturing.
Handling 1,3-Butanediol safely involves respect for its moderate toxicity and ability to irritate mucous membranes. Standard safety data sheets recommend gloves, eye protection, and adequate ventilation, echoing the everyday discipline of laboratory and production teams. Ingestion, while not as hazardous as some glycols, produces central nervous system effects, so food and pharmaceutical applications adhere to strict intake limits and high-purity benchmarks. Fire risk stays low at room temperature due to limited volatility, but prudent handling in storage—no open flames, tightly shut containers—significantly lowers accident risk. Every process operator benefits from proper hazard communication on labels, staff training, and up-to-date knowledge on spill and first-responder procedures, as prescribed by OSHA, EU REACH, and similar frameworks.
1,3-Butanediol serves as a versatile ingredient—not just in industry, but in everyday products many families use. The pharmaceutical sector employs it as a solvent for oral and topical preparations, as a matrix material for controlled-release tablets, and as a core excipient in injectable solutions. Cosmetic manufacturers use it as a humectant, lending skin-care serums and creams a pleasing consistency and improved hydration profile. The food industry accepts it as a flavoring agent and stabilizer, often replacing lower-purity glycols in diet or medical nutrition products. Polymer chemists tap into its diol structure to make polyesters, polyurethane foams, and biodegradable plastics. Its reach stretches across household, personal care, medical, and industrial product lines.
Recent years have brought a surge in R&D around 1,3-Butanediol, especially in the race toward renewable feedstocks and sustainable chemical processes. Scientists explore how engineered yeast or bacteria can turn corn starch, sugarcane, or even lignocellulosic waste into this valuable diol. These experiments go hand-in-hand with efforts to reduce raw material costs and lower the environmental footprint of specialty chemicals. In pharma tech, researchers study novel prodrugs that use 1,3-Butanediol linkages to release active molecules gradually, improving outcomes for chronic care patients. Analytical chemists work to refine detection, quantification, and impurity characterization techniques, to further tighten up registration dossiers and compliance records that regulators require. The chemistry teaching community, too, keeps it in rotation as a model substrate in undergraduate and graduate synthesis training, ensuring new scientists gain hands-on experience with practical, real-world reagents.
The safety record of 1,3-Butanediol draws from decades of animal and human studies, with the overall toxicity profile indicating moderate danger at high doses but low acute hazard in small, regulated concentrations. Early animal data flagged liver enzyme changes and mild, reversible CNS depression—insights that have guided risk assessment and exposure controls. Ingested doses metabolize to beta-hydroxybutyrate, a compound the body naturally produces during ketosis, so medical nutrition experts pay attention to both the beneficial and unwanted metabolic effects. Regulatory agencies in Europe, the United States, and Asia set strict thresholds for daily exposure, especially in products for children and the elderly. Ongoing research tracks emerging data on chronic exposure and subtle developmental effects, feeding into continuous improvement in safety standards and pharmacopoeial monographs.
The outlook for 1,3-Butanediol hinges on its established roles and emerging green credentials. Chemical firms pursue biobased variants to meet growing demand for sustainable materials, especially as consumer brands adopt science-backed sustainability claims. Elective medical and wellness markets test ketone supplements made with this diol, nudging it into fitness and personalized nutrition spaces. The evolving regulatory climate prompts more extensive, globally harmonized standards, with digital tracking of raw material provenance and compliance. Synthetic organic chemists keep expanding the family of derivatives used in active pharmaceutical ingredients and new polymer architectures. With tighter regulations around glycol impurities and continual improvement cycles in manufacturing, those who work at every stage of the value chain—from farm to formulation lab to factory floor—find themselves shaping the next chapter for this unassuming, yet essential, chemical.
Walk through the back halls of most pharmaceutical manufacturing plants, and you’ll see tanks marked with names you barely recognize. Among these, 1,3-Butanediol shows up time and again, especially when the label spells out BP, EP, or USP. These marks stand for British, European, and United States Pharmacopeia, meaning the compound meets the purity levels set for drugs and medical products. This isn’t just about following rules. If you've ever worked near a quality assurance bench, you know why these standards exist: tiny amounts of contamination can lead to big trouble for patients.
This liquid often builds the foundation for many popular drug formulations. Think of it as a behind-the-scenes helper that keeps tablets, capsules, and syrups safe and stable through the long journey from factory to pharmacy. Its chemical structure lets it mix easily with water and many solvents. That property makes the job much smoother for pharmaceutical chemists formulating medicines that need to dissolve easily or stay preserved over time.
Working on product development, I’ve seen how a good excipient doesn’t just pad out the tablet; it keeps medicine working as promised until the last pill in the bottle. The low toxicity of 1,3-Butanediol means it can serve as a solvent or carrier without endangering patients. Many cough syrups and oral suspensions use it, usually to keep active ingredients dissolved and protect them from breaking down before the patient even has a chance to use them.
Reach beyond the lab, and you’ll find this compound in medical devices, creams, and ointments, too. Ever rubbed in a topical gel and wondered why it spreads so smoothly and absorbs quickly? You’re probably seeing 1,3-Butanediol at work. Its ability to attract just enough moisture helps keep products from drying out or turning sticky—even after months on a shelf.
I've spent long hours in R&D discussing which excipient will provide the best texture, shelf-life, and safety profile. In those meetings, regulatory compliance never left the table. Any excipient that carries a major pharmacopeia stamp immediately earns more trust for everyone at that table. Patients never see these hurdles, but they benefit from the end result—a safer, more reliable medicine.
Chemical quality matters hugely in this business. Impurities pose risk, and even slight lapses in process management can lead to products getting pulled off shelves. Trusted suppliers test 1,3-Butanediol for purity at every step: from raw material to storage. Regular audits and traceability logs should back every drum that enters a plant.
Many researchers and manufacturers keep an eye out for alternatives. Some push for ‘greener’ processes to minimize environmental impact. Others hunt for new additives that combine similar safety levels with reduced cost. Industry groups often organize workshops sharing the latest data—cross-pollination from different sectors has sparked improvements in both sustainability and safety.
In my years around drug development, the role of excipients like 1,3-Butanediol has expanded steadily. It carries weight not because it’s flashy, but because it makes modern medicine safer to make, to ship, and to use. Keeping communication open between chemists, doctors, and regulators remains one of the strongest ways to push improvements in both the quality and ethical sourcing of this important ingredient.
In the lab, a small impurity can throw a project off course. The same goes for manufacturing settings, where a batch containing even low levels of contaminants risks product failure or worse, a safety incident. Every major recall I've followed in the news could trace its root cause back to gaps in verifying product specifications. Purity isn’t just a box to check. It changes outcomes.
Purity specifications give both buyers and sellers a common language. These numbers—say, minimum assay, or maximum allowable contaminants like heavy metals or residual solvents—signal to end users that what they receive lines up with published safety data. Most products used in pharmaceuticals or food industries face regulations from FDA and international bodies like the European Pharmacopoeia. They set strict thresholds for things like lead, arsenic, or unwanted by-products. Regular batch testing, certificates of analysis, and audits keep everyone honest.
Some companies try to chase maximum yield, sometimes at the expense of tighter controls. Maintaining tight purity specs takes investment: precise filtration, validated equipment, and staff who pay attention to detail. Once saw a plant skip a step in their purification cycle, thinking a shortcut would save them time. The product failed release, and that batch cost the company more than any time saved. That lesson spread through the company and brought more focus to in-line testing, especially for products used in sensitive environments.
Labs and suppliers who take quality seriously deploy extensive checks. Gas chromatography, infrared spectroscopy, and wet chemistry tests track each possible contaminant. Real people in those labs weigh risks, knowing that a green light in the data isn’t enough without documentation. Extended audits from global customers put every process under the microscope. I’ve watched as changes in raw material sourcing forced a supplier to retest entire lots—and how that vigilance built stronger trust between partners.
Stories abound of products pulled off shelves, or contracts lost, after failing compliance audits. The headlines never tell the full price—damaged relationships, urgent recalls, sometimes legal battles. One misstep in standards can ripple throughout a supply chain, especially in medical and food industries. I’ve sat in meetings where a single deviation in purity specs forced senior leaders to scramble, not just to replace a product, but also to repair trust.
Tighter purity starts with knowing your supply chain. Trusted vendors, transparent records, and independent batch testing gave my teams the confidence to meet compliance requirements. Investing in training keeps employees sharp to evolving standards. I’ve pushed for clearer labeling and certification, so no one down the chain has to guess whether a product matches the published spec sheet. In the real world, that attention to detail saves reputations and makes sure products actually do their intended job.
Everyday people count on medicine and personal care items to keep healthy, feel good, or treat problems. Whether someone picks up a bottle of pain reliever from the pharmacy or applies lotion to dry skin, they trust that what touches them—or goes inside them—won’t do harm. That trust starts with picking the right grade of ingredients. Every step leads back to one question: is this material pure and consistent enough for direct use on skin or inside the body?
Any drug manufacturer knows cutting corners on ingredient quality puts real lives at risk. The United States Pharmacopeia (USP), British Pharmacopoeia (BP), and European Pharmacopoeia set tough benchmarks for purity, contaminants, and identity. Failure to meet those rules can ruin batch after batch and spark massive recalls.
Expert teams look closely at levels of everything, from heavy metals to microbiological safety. Exacting lab tests confirm that these standards are met every single time, not just in the first batch. Products hit the shelves only if every component passes—the supplier’s word alone never replaces proper analysis. When I worked in a pharmacy, we checked for documented standards on every raw material used to make capsules right down to the coloring agents. Anything less would risk both safety and trust.
The drug world also requires full traceability, so everybody knows where an ingredient started and how it moved through the chain. Even a small mistake can mean big problems, since strict regulators such as the FDA or EMA inspect supply chains without warning. That’s the only way to keep contaminants, fake materials, or unapproved additives from sneaking in. A supplier offering pharmaceutical grade needs certification and a clean track record—no shortcuts allowed.
Cosmetic products—shampoos, creams, makeup—don’t get swallowed but still make fast, direct contact with sensitive skin and eyes. People assume their face wash or sunscreen won’t cause trouble. Ingredients won’t meet the same tough rules as tablets, but that doesn’t mean just anything goes. European and U.S. laws require cosmetic grade materials keep out toxic metals, dangerous bacteria, and things like formaldehyde or benzene above set limits. Some ingredients need more careful review, since skin can react fast to impurities or harsh solvents.
Suppliers and brands need testing records and clear documentation. Companies with experience in this field look for independent quality audits. If consumers report rashes or reactions, brands who know their supply partners avoid blame. On the floor of a skincare startup I once visited, the chemists quizzed their vendors, ran in-house tests, and sometimes sent samples for third-party analysis before scaling up to full production. One careless ingredient could ruin trust the team took years to build.
No one wants to worry about the safety of what they use every day. That’s why buyers ask about certifications like cGMP, ISO standards, or compliance documents from trusted authorities. Auditing sources in person, checking every new batch, and tracking each shipment all help brands and manufacturers spot risk fast.
Public access to lab results or regulatory filings pushes suppliers to stay honest. As more customers ask questions or dig behind labels, the more pressure suppliers face to improve. Retailers, brand owners, and consumers have the power to demand—and get—greater transparency and control through their choices and questions.
Every step in the journey, from raw material to bathroom shelf, shapes trust. Pharmaceutical and cosmetic products rely on the invisible work done by those choosing the right grade. That’s worth protecting, for everyone’s peace of mind.
Anyone who has handled active pharmaceutical ingredients like 1,3-Butanediol BP EP USP pharma grade knows packaging and storage may shape not only performance but safety and shelf life. With so many regulations in place for pharmaceuticals, there’s little room for error in transport or long-term warehousing.
Most of the time, 1,3-Butanediol in pharma grade turns up in high-density polyethylene (HDPE) drums, usually 200 liters or smaller. Some manufacturers offer it in intermediate bulk containers—those 1,000-liter IBC totes—for big buyers. Glass bottles sometimes pop up when people want very small, laboratory samples.
It’s tempting to cut costs with cheaper plastics, but that’s a gamble. Cheaper containers can easily leach chemicals or react with the diol, risking contamination. HDPE drums have a strong reputation for blocking both water and oxygen transfer, and over the years, I’ve developed respect for suppliers who never compromise on this point. Besides being chemically compatible, HDPE carries international evidence of handling frequent rough treatment during global transit.
Tamper-evident seals and secure lids are a must. Someone who has spent enough time tracking raw materials for pharmaceutical clients will recognize the headaches caused by loose caps or sloppy seals. Leaks or airborne moisture bring in both contamination risk and lost volume, which nobody in pharmaceutical QC wants to sort out.
Every facility I’ve walked through—especially the reliable ones—keeps a tight rein on exposure to temperature swings and sunlight. 1,3-Butanediol holds up as a liquid at room temperature; it doesn’t need refrigeration. Even so, consistency counts. Wide temperature fluctuations speed up degradation and could defeat years of stability studies.
Direct sunlight also spells trouble. Not because of crumbling plastic so much as the heat and the usually slow but irreversible breakdown of sensitive molecules in the drum. Even fluorescent lights have been flagged in some audits, after companies noticed slight yellowing due to long-term exposure. Maybe it sounds obsessive, but consistent results require strict protocols.
Properly managed storage rooms offer dry and dust-free environments. Humidity control matters, given that even small water infiltration alters 1,3-Butanediol’s purity. Desiccant packs sometimes show up in storerooms for added safety. Stackability has limits, and responsible facilities follow guidance that prevents heavy stacking and drum deformation—no one wants even microscopic cracks where bacteria or dirt can slip in.
GMP-certified sites track every lot using barcode or RFID systems, making sure no expired batch stays hidden in a corner. This doesn’t just keep regulators happy; it helps technicians quickly identify out-of-date stock and prevents mix-ups that could spoil entire blends.
Modern storage isn’t perfect, and keeping every delivery pristine takes vigilance. Upgraded tamper-proof seals, more frequent audits, even real-time container monitoring (temperature, humidity) with IoT sensors promise to close some gaps. I wouldn’t underestimate staff training—workers who see the connection between simple slip-ups and downstream recalls approach each drum with extra care.
From the engineer devising robust HDPE drums to the warehouse technician logging each arrival, every step influences safety and quality. The deeper I’ve gone behind the scenes, the clearer it is: packaging and storage of 1,3-Butanediol represents far more than a supply chain chore—it’s a defining part of responsible pharmaceutical practice.
Every time I visit a supplier or test out a new ingredient for a project, the first thing I ask about is the documentation. If the company shrugs off requests for a Certificate of Analysis (COA) or avoids talking about regulatory records, it raises a big red flag. No matter what industry—food, supplements, chemicals, or cosmetics—this basic paperwork isn’t just bureaucracy. It’s the backbone of trust and transparency between producers, distributors, and consumers.
I’ve sat across tables with skeptical clients who worry about what actually goes into the products they buy. A legitimate COA, signed and dated by a qualified lab, spells out precisely what’s in the batch. It lists specifics like purity, contaminants, and sometimes even origin. If I wanted to be sure my protein powder didn’t contain heavy metals, I’d ask for that report. These details help people make informed choices, protect businesses from liability, and can even save lives in critical products like medication or food.
Ask any manufacturer in the United States about FDA audits, and you’ll see a look of respect and maybe a little fear. Regulatory documentation extends far beyond a one-page printout, including everything from batch records to safety data sheets. In my own work, I’ve witnessed delays and recalls where a missing or incorrect documentation pack led to tens of thousands of dollars lost and dented reputations. With global trade, differences pop up: the same product might require different records in Europe, North America, or Asia. Companies that want to stay in business adapt, hire compliance specialists, and back up every shipment with traceable paperwork.
While some businesses claim documentation delays production or adds costs, skipping the process is shortsighted. I’ve encountered labs that fabricate COAs or rely on template paperwork. That approach unravels in real life—think of recent health scares where contaminants showed up in food or vitamins, traced back to poor records. Consumers don’t forgive this stuff easily. Online forums and social media turn small problems into public scandals.
There’s some good news. Digital solutions are making paperwork faster and easier to track, cutting the lag between orders and delivery. Blockchain systems, though still new for most companies, already offer permanent records that can’t be altered or lost. Some brands hand over complete documentation with a QR code right on the label. In regulated industries, investing in trained compliance staff pays for itself, smoothing audits and giving buyers peace of mind. I’ve seen smaller companies pool resources to access third-party labs, saving costs without sacrificing accuracy.
People sometimes feel awkward pushing for documentation, especially if they like a supplier’s price or branding. I’ve learned to keep asking until I see the records for myself. The companies that see documentation as an afterthought rarely earn lasting trust. Those that show clear, timely paperwork stick around, gaining loyal customers in a world that can afford fewer shortcuts.
| Identifiers | |
| ECHA InfoCard | 03e9431f-cd2e-4651-8d80-965adffa7e3d |
Chengguan District, Lanzhou, Gansu, China
